Vesnarinone, a differentiation inducing drug, directly activates p21(waf1) gene promoter via Sp1 sites in a human salivary gland cancer cell line

類似資料

• Induction of TSC-22 by treatment with a new anti-cancer drug, vesnarinone, in a human salivary gland cancer cell.
  著者:: Kawamata, H., 等
  出版事項: (1998)
• Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines
  著者:: Uchida, D, 等
  出版事項: (2001)
• Myc represses the p21((WAF1/CIP1)) promoter and interacts with Sp1/Sp3
  著者:: Gartel, Andrei L., 等
  出版事項: (2001)
• Unique induction of p21(WAF1/CIP1)expression by vinorelbine in androgen-independent prostate cancer cells
  著者:: Liu, X M, 等
  出版事項: (2003)
• Determination of the origin of oral squamous cell carcinoma by microarray analysis: Squamous epithelium or minor salivary gland?
  著者:: Kinouchi, Makoto, 等
  出版事項: (2018)